| Literature DB >> 32933533 |
A Seweryn1, M Alicka2, A Fal3, K Kornicka-Garbowska2,4, K Lawniczak-Jablonska1, M Ozga1, P Kuzmiuk1, M Godlewski1, K Marycz5,6,7.
Abstract
BACKGROUND: Due to increaEntities:
Keywords: Atomic layer deposition; Biomaterials; Hafnium (IV) oxide; Osteoblasts; Osteoclasts; Osteoporosis
Mesh:
Substances:
Year: 2020 PMID: 32933533 PMCID: PMC7493872 DOI: 10.1186/s12951-020-00692-5
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1Spectrum of XPS measured over a wide range of elements binding energy (a), only O, Hf and C were detected. The distribution of elements: Hf, O and C as a function of Ar+ spattering time (b), high resolution O 1 s line decomposed into two components: bonded with Hf (blue line) and atmospheric contamination (red line) (c), hafnium 4f 7/2 (red line) and 4f 5/2 (blue line) spin –orbit doublet before sputtering (d) and after sputtering (e), the second spin–orbit doublet should be added to account for Hf bonded with less than 7 oxygen atoms. The AFM images of obtained HfO2 thin layer: top view of scan area equal to 4 μm2 (f) and three-dimensional view of scan area of 100 μm2(g)
Fig. 2Temporal dynamic of MC3T3 and 4B12 proliferation activity. Cells were cultivated under normal growth condition or in the presence of HfO2. Proliferation rate of MC3T3 and 4B12 was estimated using resazurin-based in vitro toxicology (TOX8) assay kit (a). Population doubling time (PDT) value of MC3T3 and 4B12 cells was determined using TOX8 assay results (b). Error bars represent the means ± SD. *p < 0.05, ***p < 0.001; Student’s t test
Fig. 3The effect of HfO2 on the expression of apoptosis-related genes and miRNAs in MC3T3-E1 and 4B12 cells after 144 h of culture. Expression pattern of CASP9, P53, BCl2 and BAX was determined using RT-qPCR method (A-B). BCL2/BAX ratio was calculated based on relative expression of those genes. GAPDH was used as housekeeping gene. The relative level of miR-7a and miR-17-5p was estimated with Mir-X-system using RT-qPCR method (C-D). U6 was used as normalization control. Error bars represent the means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t test
Fig. 4Expression of mRNA, miRNA and cellular localization of proteins involved in osteogenic differentiation in MC3T3 cells cultured on standard glass slides or on the glass slides covered with HfO2 for 144 h. Relative expression of TGFB, RUNX2, OPN and OCN was determined using RT-qPCR method (a). GAPDH was used as normalization control. Relative expression of osteogenesis-related miRNA (b). U6 was used as endogenous control for miRNA qPCR. Additionally, immunufluorescence for RUNX2 (c), OPN (d) and OPG (e) were performed. Error bars represent the means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t test. Representative images of immunofluorescence staining for RUNX2, OPG and OPN (Z-projects) (green: Atto 488, blue: DAPI) (c). Scale bar is equal 50 µm
Fig. 5Expression of osteoclast-specific genes in 4B12 cells after 144 h of culture in normal condition or in the presence of HfO2. mRNA level of c.FOS, MMP9, PU.1, RANK, TRAP and CR1A was determined using RT-qPCR method. Gene expression data was normalized to the expression of GAPDH. Error bars represent the means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t test
Fig. 6Representative images of staining for F-actin structures in RAW 264.7 after 4 h (a) and 24 h (b) incubation with LPS. F-actin was stained with Phalloidin 590, while cell nuclei were counterstained with DAPI (blue). White arrows indicated morphological alternations of macrophages after LPS treatment. Scale bar is equal 50 µm
Fig. 7Changes in the expression of pro- and anti-inflammatory cytokines. Relative expression of cytokines was assessed after 4 h (a, b) and 24 h (c, d) stimulation with LPS using RT-qPCR method. GAPDH was used as housekeeping gene. Error bars represent the means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001; Two-way ANOVA analysis of variance followed by Bonferroni post hoc testes
Sequence of primers used for mRNA expression analysis using RT-qPCR method
| Gene abbreviation | Gene full name | Sequence of primer (5′ → 3′) | Amplicon lenght | Accession No. |
|---|---|---|---|---|
| Caspase-9 | F: CCGGTGGACATTGGTTCTGG | 278 | NM_001355176.1 | |
| R: GCCATCTCCATCAAAGCCGT | ||||
| p53 tumor suppressor | F: AGTCACAGCACATGACGGAGG | 287 | XM_030245924.1 | |
| R: GGAGTCTTCCAGTGTGATGATGG | ||||
| B-cell lymphoma 2 | F: GGATCCAGGATAACGGAGGC | 141 | NM_009741.5 | |
| R: ATGCACCCAGAGTGATGCAG | ||||
| Bcl-2-like protein 4 | F: AGGACGCATCCACCAAGAAGC | 251 | XM_011250780.3 | |
| R: GGTTCTGATCAGCTCGGGCA | ||||
| Transforming growth factor beta 1 | F: GGAGAGCCCTGGATACCAAC | 94 | NM_011577.2 | |
| R: CAACCCAGGTCCTTCCTAAA | ||||
| Runt-related transcription factor 2 | F: TCCGAAATGCCTCTGCTGTT | 130 | NM_001271630.1 | |
| R: GCCACTTGGGGAGGATTTGT | ||||
| Osteopontin | F: AGACCATGCAGAGAGCGAG | 340 | NM_001204203.1 | |
| R: GCCCTTTCCGTTGTTGTCCT | ||||
| Osteocalcin | F: GGTGCAGACCTAGCAGACACCA | 100 | NM_001032298.3 | |
| R: CGCTGGGCTTGGCATCTGTAA | ||||
| c-fos proto-oncogene | F: CCAGTCAAGAGCATCAGCAA | 248 | NM_010234.3 | |
| R: TAAGTAGTGCAGCCCGGAGT | ||||
| Matrix metallopeptidase 9 | F: TTGCCCCTACTGGAAGGTATTAT | 172 | XM_006498861.3 | |
| R: GAGAATCTCTGAGCAATCCTTGA | ||||
| Transcription factor PU.1 | F: GAGAAGCTGATGGCTTGGAG | 175 | XM_017316733.2 | |
| R: TTGTGCTTGGACGAGAACTG | ||||
| Receptor activator of nuclear factor κ B | F: TTAAGCCAGTGCTTCACGGG | 473 | NM_009399.3 | |
| R: ACGTAGACCACGATGATGTCGC | ||||
| Tartrate-resistant acid phosphatase | F: GTCTCTGGGGGACAATTTCTACT | 241 | XM_006509945.3 | |
| R: GTTTGTACGTGGAATTTTGAAGC | ||||
| Calcitonin receptor isoform 1a | F: TGCGGCGGGATCCTATAA | 238 | NM_001355192.1 | |
| R: AGCCAGCAGTTGTCGTTGTA | ||||
| Nitric oxide synthase | F: GACAAGCTGCATGTGACATC | 325 | NM_001313922.1 | |
| R: GCTGGTAGGTTCCTGTTGTT | ||||
| Tumor necrosis factor α | F: ACAGAAAGCATGATCCGCGA | 295 | NM_013693.3 | |
| R: CTTGGTGGTTTGCTACGACG | ||||
| Interleukin 6 | F:GAGGATACCACTCCCAACAGACC | 141 | NM_001314054.1 | |
| R:AAGTGCATCATCGTTGTTCATACA | ||||
| Interleukin 1 beta | F: TGCCACCTTTTGACAGTGATG | 138 | NM_008361.4 | |
| R: TGATGTGCTGCTGCGAGATT | ||||
| Interleukin 10 | F: ATTTGAATTCCCTGGGTGAGAAG | 75 | NM_010548.2 | |
| R: CACAGGGGAGAAATCGATGACA | ||||
| Interleukin 4 | F: GAATGTACCAGGAGCCATAT | 385 | NM_021283.2 | |
| R: CTCAGTACTACGAGTAATCCA | ||||
| Glyceraldehyde 3-phosphate dehydrogenase | F: TGCACCACCAACTGCTTAG | 177 | XM_017321385.2 | |
| R: GGATGCAGGGATGATGTTC |
Sequence of primers used for miRNA expression analysis using qPCR method
| miRNA | Sequence of primer (5′ → 3′) | Accession No. |
|---|---|---|
| miR-7a-5p | TGGAAGACTAGTGATTTTGTTGT | MIMAT0000677 |
| miR-17-5p | CAAAGTGCTTACAGTGCAGGTAG | MIMAT0000070 |
| miR-21-5p | TAGCTTATCAGACTGATGTTGA | MIMAT0000530 |
| miR-16-5p | TAGCAGCACGTAAATATTGGCG | MIMAT0000069 |